HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SF 1126

an LY294002 prodrug and pan PI3K inhibitor; structure in first source
Also Known As:
SF-1126; SF1126
Networked: 11 relevant articles (0 outcomes, 6 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Durden, Donald L: 9 articles (03/2015 - 01/2008)
2. Joshi, Shweta: 5 articles (03/2015 - 01/2014)
3. Singh, Alok R: 5 articles (03/2015 - 01/2014)
4. Peirce, Susan K: 2 articles (09/2014 - 08/2011)
5. Garlich, Joseph R: 2 articles (04/2013 - 01/2008)
6. De, Pradip: 2 articles (04/2013 - 01/2008)
7. Dey, Nandini: 2 articles (04/2013 - 01/2008)
8. Liu, Dechun: 1 article (04/2015)
9. Chen, Yanbin: 1 article (04/2015)
10. Deng, Miao: 1 article (04/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Hematologic Neoplasms (Hematological Malignancy)
4. Neuroblastoma
5. Glioma (Gliomas)

Related Drugs and Biologics

1. Phosphatidylinositol 3-Kinases
2. Phosphotransferases (Kinase)
3. Proteasome Endopeptidase Complex (Proteasome)
4. Vitronectin
5. bortezomib (Velcade)
6. trastuzumab (Herceptin)
7. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
8. Integrin alphaVbeta3
9. Cyclin D1
10. Anthracyclines

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Subcutaneous Injections
3. Drug Therapy (Chemotherapy)